IFT20 and breast cancer: The consistent downregulation of IFT20 in the breast cancer cells with a manner corresponding to the malignancy potential suggests that the expression of IFT20 may be negatively correlated with breast cancer progression; this association was independent of both cilia and the classical IFT complex.